Pharmacokinetics of p -aminohippuric acid and inulin in rabbits with aristolochic acid nephropathy

Advances in Pharmacological Sciences

Volumn 2011, Issue , 2011, Pages

  Hsu, Kuang Yang ^a   Tseng, Chiao Shih ^a   Chen, Shih Ming ^a   Chien, Shu Chen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ARISTOLOCHIC ACID; INULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 80052708220     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2011/204501     Document Type: Article

References (44)

1. Vanherweghem J. L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., Vanhaelen-Fastre R., Vanhaelen M., Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs Lancet 1993 341 8842 387 391 (Pubitemid 23048140)
2. Vanhaelen M., Vanhaelen-Fastre R., But P., Vanherweghem J. L., Identification of aristolochic acid in Chinese herbs Lancet 1994 343 8890 174 (Pubitemid 24028653)
3. Krumbiegel G., Hallensleben J., Mennicke W. H., Rittmann N., Roth H. J., Studies on the metabolism of aristolochic acids I and II Xenobiotica 1987 17 8 981 991 (Pubitemid 17150543)
4. Nortier J. L., Martinez M. C. M., Schmeiser H. H., Arlt V. M., Bieler C. A., Petein M., Depierreux M. F., De Pauw L., Abramowicz D., Vereerstraeten P., Vanherweghem J. L., Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) New England Journal of Medicine 2000 342 23 1686 1692 (Pubitemid 30354515)
5. Cosyns J. P., Dehoux J. P., Guiot Y., Goebbels R. M., Robert A., Bernard A. M., Van Ypersele De Strihou C., Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney International 2001 59 6 2164 2173 (Pubitemid 32467608)
6. Vanherweghem J. L., Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) Journal of Alternative and Complementary Medicine 1998 4 1 9 13
7. Stengel B., Jones E., End-stage renal insufficiency associated with Chinese herbal consumption in France Nephrologie 1998 19 15 20 (Pubitemid 28114312)
8. Pea J. M., Borrs M., Ramos J., Montoliu J., Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion Nephrology Dialysis Transplantation 1996 11 7 1359 1360 (Pubitemid 26241433)
9. Lord G. M., Tagore R., Cook T., Gower P., Pusey C. D., Nephropathy caused by chinese herbs in the UK Lancet 1999 354 9177 481 482 (Pubitemid 29368929)
10. Cronin A. J., Maidment G., Cook T., Kite G. C., Simmonds M. S. J., Pusey C. D., Lord G. M., Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy Nephrology Dialysis Transplantation 2002 17 3 524 525 (Pubitemid 34211163)
11. Meyer M. M., Chen T. P., Bennett W. M., Chinese herb nephropathy Baylor University Medical Center Proceedings 2000 13 334 337
12. Chang C. H., Wang Y. M., Yang A. H., Chiang S. S., Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications American Journal of Nephrology 2001 21 6 441 448
13. FDA: U.S. Department of Health and Human Servcices. Aristolochic Acid: FDA warns consumers to discontinue use of botanical products that contain aristolochic acid, 2001, http://www.fda.gov/Food/DietarySupplements/Alerts/ ucm096388.htm
14. Gold L. S., Slone T. H., Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert New England Journal of Medicine 2003 349 16 1576 1577 (Pubitemid 37255048)
15. Cosyns J. P., Jadoul M., Squifflet J. P., De Plaen J. F., Ferluga D., Van Ypersele De Strihou C., Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney International 1994 45 6 1680 1688 (Pubitemid 24207504)
16. Depierreux M., Van Damme B., Houte K. V., Vanherweghem J. L., Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs American Journal of Kidney Diseases 1994 24 2 172 180 (Pubitemid 24249054)
17. Chen S. M., Fan M. Y., Tseng C. C., Ho Y., Hsu K. Y., Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits Toxicon 2007 50 2 180 188 (Pubitemid 47042137)
18. Sato N., Takahashi D., Chen S. M., Tsuchiya R., Mukoyama T., Yamagata S. I., Ogawa M., Yoshida M., Kondo S., Satoh N., Ueda S., Acute nephrotoxicity of aristolochic acids in mice Journal of Pharmacy and Pharmacology 2004 56 2 221 229 (Pubitemid 38232752)
19. Debelle F. D., Nortier J. L., De Prez E. G., Garbar C. H., Vienne A. R., Salmon I. J., Deschodt-Lanckman M. M., Vanherweghem J. L., Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats Journal of the American Society of Nephrology 2002 13 2 431 436 (Pubitemid 34106285)
20. Shah V. P., Midha K. K., Dighe S., McGilveray I. J., Skelly J. P., Yacobi A., Layloff T., Viswanathan C. T., Edgar Cook C., McDowall R. D., Pittman K. A., Spector S., Albert K. S., Bolton S., Edgar Cook C., Dobrinska M., Doub W., Eichelbaum M., Findlay J. W. A., Gallicano K., Garland W., Hardy D. J., Hulse J. D., Thomas Karnes H., McDowall R. D., Lange R., Mason W. D., McKay G., Ormsby E., Overpeck J., Plattenberg H. D., Sha V. P., Shiu G., Sitar D., Sorgel F., Stewart J. T., Viswanathan C. T., Yuh L., Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies Pharmaceutical Research 1992 9 588 592
21. Shumaker R. C., PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data Drug Metabolism Reviews 1986 17 3-4 331 348 (Pubitemid 17044697)
22. Sci Software. WinNonlin, 1995
23. Gouyon J. B., Guignard J. P., Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits Kidney International 1988 33 6 1078 1083
24. Tett S. E., Kirkpatrick C. M. J., Gross A. S., McLachlan A. J., Principles and clinical application of assessing alterations in renal elimination pathways Clinical Pharmacokinetics 2003 42 14 1193 1211 (Pubitemid 37491486)
25. Van Olden R. W., Van Acker B. A. C., Koomen G. C. M., Krediet R. T., Arisz L., Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients Clinical Nephrology 1998 49 3 167 172 (Pubitemid 28130199)
26. Hong Y. T., Fu L. S., Chung L. H., Hung S. C., Huang Y. T., Chi C. S., Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs Pediatric Nephrology 2006 21 4 577 579
27. Li Y., Liu Z., Guo X., Shu J., Chen Z., Li L., Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro Archives of Toxicology 2006 80 8 524 532 (Pubitemid 43979680)
28. Bonate P. L., Reith K., Weir S., Drug interactions at the renal level: implications for drug development Clinical Pharmacokinetics 1998 34 5 375 404 (Pubitemid 28192907)
29. Sweet D. H., Bush K. T., Nigam S. K., The organic anion transporter family: from physiology to ontogeny and the clinic American Journal of Physiology 2001 281 2 F197 F205
30. Robertson E. E., Rankin G. O., Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion Pharmacology and Therapeutics 2006 109 3 399 412 (Pubitemid 43132819)
31. Sekine T., Cha S. H., Endou H., The multispecific organic anion transporter (OAT) family Pflugers Archiv European Journal of Physiology 2000 440 3 337 350 (Pubitemid 30445708)
32. Pedrotti A., Bonjour J. P., Guignard J. P., Protection from hypoxemia-induced renal dysfunction by the thiophosphate WR-2721 Kidney International 1992 41 1 80 87
33. Semama D., Heumann C., Guignard J. P., Protection from hypoxemic renal dysfunction by verapamil and manganese in the rabbit Life Sciences 1995 56 4 231 239 (Pubitemid 124015446)
34. Prévot A., Semama D. S., Justrabo E., Guignard J. P., Escousse A., Gouyon J. B., Acute cyclosporine A-induced nephrotoxicity: a rabbit model Pediatric Nephrology 2000 14 5 370 375 (Pubitemid 30216186)
35. Prévot A., Huet F., Semama D. S., Gouyon J. B., Guignard J. P., Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit Life Sciences 2002 71 7 779 787 (Pubitemid 34628820)
36. Sun D., Feng J., Dai C., Sun LI., Jin T., Ma J., Wang L., Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy American Journal of Nephrology 2006 26 4 363 371 (Pubitemid 44394155)
37. Yang L., Li X., Wang H., Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis Nephrology Dialysis Transplantation 2007 22 2 445 456 (Pubitemid 46189888)
38. Choi Y. J., Chakraborty S., Nguyen V., Nguyen C., Kim B. K., Shim S. I., Suki W. N., Truong L. D., Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor Human Pathology 2000 31 12 1491 1497 (Pubitemid 32049007)
39. Huet F., Gouyon J. B., Guignard J. P., Prevention of hypoxemia-induced renal dysfunction by perindoprilat in the rabbit Life Sciences 1997 61 22 2157 2165 (Pubitemid 27521198)
40. Pichette V., Geadah D., Du Souich P., Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit Drug Metabolism and Disposition 1999 27 1 81 85 (Pubitemid 29061004)
41. Costanzo L. S., Physiology 2006 Philadelphia, Pa, USA Sauders Elsevier
42. Cosyns J. P., Aristolochic acid and Chinese herbs nephropathy: a review of the evidence to date Drug Safety 2003 26 1 33 48
43. Lameire N. H., Vanholder R., Pathophysiology of ischaemic acute renal failure Best Practice and Research 2004 18 1 21 36 (Pubitemid 38949984)
44. Gaudino M., Levitt M. F., Inulin space as a measure of extracellular fluid American Journal of Physiology 1949 157 387 393